Eucomed raises objections to EMA combination guidance involving NBs
This article was originally published in Clinica
Executive Summary
The European Medicines Agency’s proposed revised version of its guidance concerning the CE marking of drug/device combination products does not improve the length of the procedure nor the related costs, says European medtech trade association, Eucomed.